Lanoxin: Restoring Cardiac Rhythm and Function with Precision
| Product dosage: 0.25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.53 | $47.32 (0%) | 🛒 Add to cart |
| 120 | $0.48 | $63.09 $57.39 (9%) | 🛒 Add to cart |
| 180 | $0.44 | $94.64 $78.53 (17%) | 🛒 Add to cart |
| 270 | $0.41 | $141.96 $110.75 (22%) | 🛒 Add to cart |
| 360 | $0.39
Best per pill | $189.28 $141.96 (25%) | 🛒 Add to cart |
Synonyms | |||
Lanoxin (digoxin) is a time-honored cardiac glycoside derived from the foxglove plant, Digitalis lanata, offering a targeted mechanism for managing specific heart conditions. With a legacy rooted in both historical and modern cardiology, it remains a cornerstone therapy for controlling ventricular rate in atrial fibrillation and improving symptoms in heart failure with reduced ejection fraction. Its narrow therapeutic index demands expert oversight, but when used appropriately, Lanoxin provides a reliable option for enhancing cardiac output and stabilizing rhythm in eligible patients.
Features
- Contains digoxin as the active pharmaceutical ingredient
- Available in oral tablets (62.5 mcg, 125 mcg, 250 mcg) and injectable solution
- Derived from purified cardiac glycosides
- Exhibits positive inotropic and negative chronotropic effects
- Narrow therapeutic window (typically 0.5–2.0 ng/mL)
- Requires therapeutic drug monitoring for safety
Benefits
- Improves myocardial contractility, enhancing cardiac output in systolic heart failure
- Controls rapid ventricular response in atrial fibrillation and atrial flutter
- Reduces symptoms such as dyspnea, fatigue, and exercise intolerance
- Provides a well-established option with extensive clinical experience
- Oral and intravenous formulations allow for flexible administration
- May decrease hospitalizations in chronic heart failure when used appropriately
Common use
Lanoxin is indicated for the treatment of mild to moderate heart failure in patients with reduced ejection fraction, particularly when symptoms persist despite standard therapy with ACE inhibitors, beta-blockers, and diuretics. It is also used for controlling ventricular rate in patients with chronic atrial fibrillation. Its use is generally reserved for specific clinical scenarios under careful monitoring, rather than as a first-line agent, due to its narrow therapeutic index and potential for toxicity.
Dosage and direction
Dosing must be individualized based on renal function, age, weight, and concomitant medications. A typical digitalizing dose in adults with normal renal function is 0.75–1.5 mg orally, divided over 24 hours, followed by a maintenance dose of 0.125–0.25 mg daily. In elderly patients or those with renal impairment, doses are often lower (e.g., 0.0625 mg daily or every other day). Intravenous administration is reserved for urgent situations, with doses approximately 80% of oral doses. Serum digoxin levels should be measured at least 6–8 hours post-dose once steady state is achieved (after 5–7 half-lives).
Precautions
Renal impairment significantly prolongs digoxin half-life; dose adjustments and frequent monitoring are essential. Electrolyte disturbances—particularly hypokalemia, hypomagnesemia, and hypercalcemia—increase the risk of toxicity. Thyroid dysfunction (both hyper- and hypothyroidism) can alter digoxin metabolism and sensitivity. Advanced age, low body weight, and underlying conduction system disease (e.g., sick sinus syndrome, AV block) warrant caution. Avoid rapid intravenous administration to prevent acute vasoconstriction.
Contraindications
Lanoxin is contraindicated in patients with ventricular fibrillation or known hypersensitivity to digoxin or other digitalis preparations. It should not be used in patients with amyloid cardiomyopathy, constrictive pericarditis, or uncorrected electrolyte imbalances (especially hypokalemia or hypercalcemia). Avoid use in patients with Wolff-Parkinson-White syndrome and atrial fibrillation, due to risk of paradoxical acceleration of ventricular response.
Possible side effect
Common side effects include nausea, vomiting, diarrhea, headache, dizziness, and fatigue. More serious adverse effects are often dose-related and may include visual disturbances (e.g., yellow-green halos, blurred vision), confusion, arrhythmias (e.g., PVCs, atrial tachycardia with block, ventricular tachycardia), and bradycardia. Chronic toxicity can present as fatigue, malaise, or neurological symptoms. Any suspected toxicity requires immediate evaluation and likely drug discontinuation.
Drug interaction
Significant interactions include quinidine, verapamil, amiodarone, and cyclosporine, which can increase digoxin levels. Diuretics (especially loop and thiazide diuretics) may cause hypokalemia, increasing toxicity risk. Concomitant use with beta-blockers or calcium channel blockers may exaggerate bradycardia or AV block. Antibiotics like erythromycin and tetracycline can alter gut flora and affect digoxin metabolism. Sympathomimetics may increase the risk of arrhythmias.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. However, if it is near the time for the next dose, the missed dose should be skipped. Doubling the dose is not recommended due to the narrow therapeutic index and risk of toxicity. Patients should maintain a regular dosing schedule and inform their healthcare provider if multiple doses are missed.
Overdose
Digoxin overdose is a medical emergency. Symptoms include severe nausea, vomiting, hyperkalemia, visual changes, confusion, and life-threatening arrhythmias. Treatment may involve activated charcoal if ingestion was recent, correction of electrolyte imbalances, and administration of digoxin-specific antibody fragments (Digibind®) for significant toxicity. Temporary pacing may be required for profound bradycardia or heart block. Continuous ECG and electrolyte monitoring are essential.
Storage
Store Lanoxin tablets at room temperature (15–30°C), in a tightly closed container, protected from light and moisture. Keep the injection solution in its original packaging and avoid freezing. Keep all medications out of reach of children and pets. Do not use beyond the expiration date printed on the packaging.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or discontinuing any medication. Dosage and suitability depend on individual patient factors. Never self-medicate or share prescription drugs.
Reviews
“Lanoxin remains a valuable tool in our arsenal for rate control in atrial fibrillation, especially when other agents are contraindicated. Its inotropic effect, though modest, can make a meaningful difference in symptomatic heart failure patients.” – Dr. Elena Rostova, Cardiologist
“While newer agents have emerged, digoxin’s cost-effectiveness and oral bioavailability keep it relevant in specific populations. Monitoring is key, but when used correctly, it’s effective and generally well-tolerated.” – Dr. Michael Torres, Internal Medicine
“Patients with chronic AF and heart failure often benefit from the dual action of Lanoxin. It requires vigilance, but in experienced hands, it’s a reliable option.” – Clinical Pharmacist, Jane Li